期刊文献+

盐酸羟考酮控释片治疗癌痛的研究进展 被引量:11

下载PDF
导出
作者 周晓敏
出处 《广西医科大学学报》 CAS 2009年第5期813-816,共4页 Journal of Guangxi Medical University
基金 李嘉诚基金会全国宁养医疗服务计划项目资助
  • 相关文献

参考文献25

  • 1李小梅,刘端祺,李红英,王艳梅.恶性肿瘤患者临终前的阿片类药物止痛回顾[J].中国肿瘤临床,2005,32(23):1358-1360. 被引量:36
  • 2孙燕, 顾慰萍..癌症三阶梯止痛指导原则[M],2002.
  • 3Kapil R, Nolting A, Roy P, et al. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers[J]. Clin Ther, 2004,26 (12) : 2 015-2 025. 被引量:1
  • 4Coluzzi F, Mattia C. Oxycodone. Pharmacological profile and clinical data in chronic pain management[J].Minerva Anestesiol, 2005, 71 (7-8) : 451-460. 被引量:1
  • 5于世英.快速持久高效的治疗癌痛新药--盐酸羟考酮控释片.中国医学论坛报,2004,30(37):13-13. 被引量:1
  • 6Mandema JW, Kaiko RF,Oshlack B, et al. Characterization and validation of a pharmacokinetic model for con- trolled-release oxycodone [J]. Br J Clin Pharmacol, 1996,42(6):747-756. 被引量:1
  • 7Salzman RT, Roberts MS, Wild J, et al. Can a controlled- release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?[J]. J Pain Symptom Manage, 1999, 18(4):271-279. 被引量:1
  • 8Stambaugh JE, Radar RF, Stambaugh MD, et al. Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled-and immediaterelease oral oxycodone in cancer pain patients[J].J Clin Pharmacol, 2001,41(5):500-506. H. 被引量:1
  • 9eiskanen T, Olkkola KT, Kalso E. Effects of bloc- king CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone[J]. Clin Pharmacol That, 1998, 64(6) : 603-611. 被引量:1
  • 10Davis MP, Varga J, Dickerson D, et al. Normal-release and controlled-release oxyeodone: pharmacokinetics, pharrnaeodynamies, and controversy[J]. Support Care Cancer, 2003,11(2):84-92. 被引量:1

二级参考文献60

  • 1哈鹰,王卫平.用大鼠静脉自身给药方法评价盐酸羟考酮的精神依赖性潜力[J].中国药物依赖性杂志,2004,13(2):109-111. 被引量:11
  • 2刘华,王蔚,郑垂志,邢雪花.癌症三阶梯止痛563例分析[J].中国肿瘤临床,2004,31(23):1346-1348. 被引量:79
  • 3李小梅,刘端祺,李红英,王艳梅.恶性肿瘤患者临终前的阿片类药物止痛回顾[J].中国肿瘤临床,2005,32(23):1358-1360. 被引量:36
  • 4孙燕.内科肿瘤学[M].北京:人民卫生出版社,1999.88. 被引量:48
  • 5[1]Kaplan R,Parris WCV,Croghan M,et al.Decrease in opioid-related adverse experiences(AE) during chronic therapy with controlled -release oxycodone(OXYCR) in cancer pain patients.14th Annual Society.Los Angeles.CA.1995,Program Book,p.A146. 被引量:1
  • 6[2]Hales ME,Fleischman R,Salzmann R,et al.Efficacy and safety of controlled-release oxycodone compared with immediate-release oxycodone:a randomized,double-blind evaluation in patients with chronic back pain.Clin H Pain,2002,15:179-183. 被引量:1
  • 7[3]Kaiko RF,Benziger D.Cheng C,et al.Analgesic onset and potency of oral controlled-release (CR) oxycodone and CR morphine.Clin Pharmacol Ther,1996b,59:130. 被引量:1
  • 8[4]Mandema JW,Kaiko RF,Oshlack B,et al.Pharmacokinetic characterization of controlled-release oxycodone.Br J Clin Pharmacol,1996,42:747-775. 被引量:1
  • 9[5]Benziger DP,Miotto J,Grandy RP,et al.A pharmacokinetic/ pharmacodynamic study of controlled-release oxycodone.H Pain Sympt Mgmt,1997,13:75-82. 被引量:1
  • 10[6]Sunshine A,Olson NZ,Colon A,et al.Analgesic efficacy of controlled-release oxycodon postoperative pain.J Clin Pharmacol,1996,36:595-603. 被引量:1

共引文献90

同被引文献88

引证文献11

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部